22.418 articles found

Toxic pediatric parkinsonism: report of a child with metabolic studies and response to treatment.

Chutorian AM, Bojko A, Heier L, Frucht S, Nygaard T, Edelberg D.

J Child Neurol · 2003-11-01

DOI: 10.1177/08830738030180111701PMID: 14696914

The adenosine A(2A) receptor as an attractive target for Parkinson's disease treatment.

Chen JF.

Drug News Perspect · 2003-11-01

DOI: 10.1358/dnp.2003.16.9.829342PMID: 14702141

Gene therapy in Parkinson's disease.

During MJ.

Expert Rev Neurother · 2003-11-01

DOI: 10.1586/14737175.3.6.729PMID: 19810875

Neuroprotective treatment for Parkinson's disease.

Aminoff MJ.

Expert Rev Neurother · 2003-11-01

DOI: 10.1586/14737175.3.6.797PMID: 19810882

Dopamine agonists and their role in Parkinson's disease treatment.

Tan EK.

Expert Rev Neurother · 2003-11-01

DOI: 10.1586/14737175.3.6.805PMID: 19810883

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE

SCHENK Dale B., MASLIAH Eliezer.

· 2003-10-31

Prevention and treatment of synucleinopathic disease

SCHENK DALE B, MASLIAH ELIEZER.

· 2003-10-31

Prevention and treatment of synucleinopathic disease

SCHENK DALE B, MASLIAH ELIEZER.

· 2003-10-31

RNA interference mediated treatment of parkinson disease using short interfering nucleic acid (siNA)

MCSWIGGEN JAMES, HAEBERLI PETER, CHOWRIRA BHARAT.

· 2003-10-31

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE

SCHENK DALE B, MASLIAH ELIEZER.

· 2003-10-31

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE

MASLIAH ELIEZER, SCHENK DALE B.

· 2003-10-31

Prevention and treatment of synucleinopathic disease

SCHENK DALE B, MASLIAH ELIEZER.

· 2003-10-31